Search by Drug Name or NDC
NDC 61958-3002-01 Sunlenca Details
Sunlenca
Sunlenca is a KIT in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Gilead Sciences. The primary component is .
Product Information
NDC | 61958-3002 |
---|---|
Product ID | 61958-3002_bd4fa706-84af-4011-a69d-663fc0a3bf6b |
Associated GPIs | |
GCN Sequence Number | 084227 |
GCN Sequence Number Description | lenacapavir sodium VIAL 463.5/1.5 SUBCUT |
HIC3 | W0N |
HIC3 Description | ANTIRETROVIRAL - CAPSID INHIBITORS |
GCN | 53433 |
HICL Sequence Number | 048555 |
HICL Sequence Number Description | LENACAPAVIR SODIUM |
Brand/Generic | Brand |
Proprietary Name | Sunlenca |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | LENACAPAVIR SODIUM |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | KIT |
Route | n/a |
Active Ingredient Strength | n/a |
Active Ingredient Units | n/a |
Substance Name | n/a |
Labeler Name | Gilead Sciences |
Pharmaceutical Class | n/a |
DEA Schedule | n/a |
Marketing Category | NDA |
Application Number | NDA215973 |
Listing Certified Through | 2024-12-31 |
Package
NDC 61958-3002-01 (61958300201)
NDC Package Code | 61958-3002-1 |
---|---|
Billing NDC | 61958300201 |
Package | 1 KIT in 1 CARTON (61958-3002-1) * 1.5 mL in 1 VIAL (61958-3004-1) |
Marketing Start Date | 2022-12-22 |
NDC Exclude Flag | N |
Pricing Information | N/A |